Published in Front Oncol on December 05, 2012
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry (2015) 1.22
A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus (2015) 0.82
Endometrial cancer and antidepressants: A nationwide population-based study. Medicine (Baltimore) (2016) 0.80
Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer. Oncotarget (2016) 0.75
Modeling and variable selection in epidemiologic analysis. Am J Public Health (1989) 15.62
Interaction revisited: the difference between two estimates. BMJ (2003) 11.97
The role of automated record linkage in the postmarketing surveillance of drug safety: a critique. Clin Pharmacol Ther (1989) 4.88
Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol (1997) 3.36
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80
Prolactin and murine mammary tumorigenesis: a review. Cancer Res (1977) 2.29
Off-label applications for SSRIs. Am Fam Physician (2003) 2.27
Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res (2006) 2.27
Confounder selection in environmental epidemiology: assessment of health effects of prenatal mercury exposure. Ann Epidemiol (2006) 2.22
Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ (2001) 2.07
Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf (2007) 1.99
Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. Int J Epidemiol (1992) 1.86
Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med (2004) 1.76
Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. J Natl Cancer Inst (1980) 1.70
From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions. Neuropsychopharmacology (2004) 1.66
Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry. PLoS One (2011) 1.50
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res (1992) 1.48
Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia (2008) 1.42
Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates. Maturitas (2010) 1.38
Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry (1998) 1.34
Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. CMAJ (2005) 1.25
Sociological influences on antidepressant prescribing. Soc Sci Med (2003) 1.24
Medication-induced hyperprolactinemia. Mayo Clin Proc (2005) 1.23
Prolactin involvement in breast cancer. Endocr Relat Cancer (1999) 1.19
Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf (2009) 1.00
Breast cancer risk among users of antidepressant medications. Epidemiology (2005) 0.99
Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management. CNS Drugs (2010) 0.99
Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. Gen Hosp Psychiatry (2005) 0.99
Breast cancer risk in a large cohort of female antidepressant medication users. Cancer Lett (2005) 0.97
Hyperprolactinemia associated with psychotropics--a review. Hum Psychopharmacol (2010) 0.97
Use of selective serotonin reuptake inhibitors and the risk of breast cancer. Am J Epidemiol (2005) 0.95
Use of antidepressant medications in relation to the incidence of breast cancer. Br J Cancer (2006) 0.94
Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology (2003) 0.93
Antidepressant use and breast cancer risk. Breast Cancer Res Treat (2005) 0.90
Long-term oral contraceptive use increases breast cancer risk in women over 55 years of age: the DOM cohort. Int J Cancer (2000) 0.90
Use of antidepressant medications and the possible association with breast cancer risk. A review. Psychother Psychosom (2003) 0.90
Prolactin and human tumourogenesis. J Neuroendocrinol (2010) 0.89
Breast cancer risk factors and age at diagnosis: an Icelandic cohort study. Int J Cancer (2002) 0.86
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks. J Intern Med (2007) 0.84
Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database. Drug Saf (2011) 0.83
Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments. J Appl Toxicol (2005) 0.83
A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency. BMC Med (2010) 0.82
SSRI use and breast cancer risk by hormone receptor status. Breast Cancer Res Treat (2007) 0.82
Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study. Eur J Clin Pharmacol (1997) 0.80
Diagnosing depression and prescribing antidepressants by primary care physicians: the impact of practice style variations. Ment Health Serv Res (2002) 0.79
Effect of prolactin and estradiol on cell proliferation in the uterus and the MXT mouse mammary neoplasm. J Natl Cancer Inst (1987) 0.78
Antidepressant pharmacoepidemiology in a general population sample. J Clin Psychopharmacol (2005) 0.77
Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA (2007) 4.25
The influence of light at night exposure on melatonin levels among Canadian rotating shift nurses. Cancer Epidemiol Biomarkers Prev (2011) 2.27
Increased risk of breast cancer associated with long-term shift work in Canada. Occup Environ Med (2013) 2.24
Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf (2007) 1.98
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60
Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am J Epidemiol (2006) 1.59
Chromophore formation in resorcinarene solutions and the visual detection of mono- and oligosaccharides. J Am Chem Soc (2002) 1.51
PGR +331 A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.37
Dietary patterns and risk of prostate cancer in Ontario, Canada. Int J Cancer (2005) 1.26
Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girls. BMC Public Health (2011) 1.09
Assessing exposure to outdoor lighting and health risks. Epidemiology (2015) 1.06
Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. J Toxicol Environ Health B Crit Rev (2008) 1.00
Anti-diabetic drug use and the risk of motor vehicle crash in the elderly. Can J Clin Pharmacol (2006) 0.98
Relationship of time since childbirth and other pregnancy factors to premenopausal breast cancer prognosis. Obstet Gynecol (2008) 0.97
Factors related to use of prostate cancer screening: the Alberta Tomorrow Project. Open Med (2007) 0.91
Smoking and other lifestyle factors in relation to erectile dysfunction. BJU Int (2005) 0.90
Mortality following unemployment in Canada, 1991-2001. BMC Public Health (2013) 0.89
Shift work, circadian gene variants and risk of breast cancer. Cancer Epidemiol (2013) 0.89
Light intensity exposure, sleep duration, physical activity, and biomarkers of melatonin among rotating shift nurses. Chronobiol Int (2009) 0.88
Suicide mortality by occupation in Canada, 1991-2001. Can J Psychiatry (2010) 0.87
Avoidable mortality for causes amenable to medical care, by occupation in Canada, 1991-2001. Can J Public Health (2011) 0.87
Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls. BMC Cancer (2008) 0.86
Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study. Pharmacoepidemiol Drug Saf (2009) 0.86
Twenty-four-hour light exposure and melatonin levels among shift workers. J Occup Environ Med (2005) 0.83
A multiplex assay for the detection and mapping of complex glycerol kinase deficiency. Clin Chem (2006) 0.83
Antipsychotic drugs and the risk of hyperglycemia in older adults without diabetes: a population-based observational study. Am J Geriatr Psychiatry (2011) 0.82
Moderate-to-vigorous intensity physical activity across the life course and risk of pre- and post-menopausal breast cancer. Breast Cancer Res Treat (2013) 0.81
Physical activity, sedentary behavior, and melatonin among rotating shift nurses. J Occup Environ Med (2011) 0.81
Emerging health risks associated with modern agriculture practices: a comprehensive study in India. Environ Res (2012) 0.80
Freshwater fish-consumption relations with total hair mercury and selenium among women in eastern China. Arch Environ Contam Toxicol (2011) 0.79
Pesticides and polychlorinated biphenyls as potential risk factors for erectile dysfunction. J Androl (2006) 0.77
A cross-sectional study of breast cancer biomarkers among shift working nurses. BMJ Open (2012) 0.77
Environmental equity research: review with focus on outdoor air pollution research methods and analytic tools. Arch Environ Occup Health (2015) 0.76
A case-control study of lifetime light intensity physical activity and breast cancer risk. Cancer Causes Control (2013) 0.76
Folate intake, alcohol consumption, and the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism: influence on prostate cancer risk and interactions. Front Oncol (2012) 0.76
Breast tissue organochlorine levels and metabolic genotypes in relation to breast cancer risk Canada. Cancer Causes Control (2004) 0.76
Continuation of statin treatment and mortality: a note of caution on excessive benefits. Arch Intern Med (2009) 0.76
Dietary predictors of concentrations of polychlorinated biphenyls in breast adipose tissue of women living in Ontario, Canada. Arch Environ Health (2003) 0.75